ZTS News and Press, Zoetis Inc. Class A From 02/05/26

The Board of Directors of Zoetis Inc . (NYSE:ZTS) has declared a dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on Tuesday, June 2, 2026, to all holders of record of the Company’s common stock as of the close of business on Monday, April 20, 2026....

2026-02-04 14:53:03 ET High-Quality Dividend Stock Investable Universe On September 1, 2024, I started tracking an investable universe of what I believe to be 50 high-quality dividend growth stocks. You can find out more about the formation of this investable universe in the origi...

2026-02-04 08:19:18 ET The reaction to fourth quarter earnings and guidance from IDEXX Labs ( IDXX ) underlines some of the perils of high-multiple stocks, particularly after periods of outperformance. There was nothing really wrong with fourth-quarter earnings or guidance, but expe...

2026-02-03 22:01:36 ET 4-Factor Dividend Growth Portfolio The 4-Factor Dividend Growth Strategy is an alternative investment strategy to the popular Schwab U.S. Dividend Equity ETF ( SCHD ). Think of it as having your own custom tailored version of SCHD designed to align wit...

2026-02-01 22:22:49 ET Quality Stocks Despite some elevated volatility in the final week of January the broad U.S. market started the year out in the green. The SPDR® S&P 500® ETF ( SPY ) posted a gain of 1.47%. Vanguard Dividend Appreciation Index Fund ETF Sha...

2026-01-29 09:39:00 ET ... Read the full article on Seeking Alpha For further details see: Artisan Global Opportunities Fund Q4 2025 Portfolio Update

2026-01-27 14:21:27 ET More on Eli Lilly, CVS , etc. HCA Healthcare: A Booming Buyback But Risks Loom (Downgrade) Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript Johnson & Johnson 2025 Q4 - Results - Earnings Call Presentation Health ins...

2026-01-24 08:00:00 ET Co-authored by Kody's Dividends Occasionally, I enjoy watching an episode or two of Shark Tank . Not necessarily because I believe in the direct success of the companies that show up there or because I enjoy the billionaire investors who appear there. What...

2026-01-22 13:25:00 ET Zoetis (NYSE: ZTS) and Regeneron Pharmaceuticals (NASDAQ: REGN) are two healthcare leaders that have lagged broader equities over the past 12 months, as both encountered headwinds that led to worse-than-expected financial results. However, following re...

2026-01-22 12:20:00 ET For the first 10 years of its publicly traded life, leading animal healthcare stock Zoetis (NYSE: ZTS) easily outpaced the S&P 500 , rising 480% and doubling the index's total returns . However, since then, Zoetis' stock has slid nearly 40%...